title: Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment.
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: Emilie P
authors.initials: EP
authors.lastname: Belley-Côté
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: Richard P
authors.initials: RP
authors.lastname: Whitlock
authors.affiliation: University of Pennsylvania, Philadelphia, PA, Philadelphia, USA.
authors.forename: Benjamin
authors.initials: B
authors.lastname: French
authors.affiliation: McMaster University, Hamilton, Ontario, Canada.
authors.forename: Nathan
authors.initials: N
authors.lastname: Evaniew
authors.affiliation: University of Pennsylvania, Philadelphia, PA, Philadelphia, USA. Electronic address: stevek@mail.med.upenn.edu.
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Kimmel
mesh_terms: D000465:Algorithms; D005260:Female; D006801:Humans; D008297:Male; D010597:Pharmacogenetics / Q000379:methods*; D013923:Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000494:pharmacology*
chemical_list: D014859:Warfarin